ArticleBioinformation2025
Mean platelet volume: A versatile biomarker in clinical diagnostics and prognostics.
Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Are Platelet Volume, Density, and the Homeostatic Blueprint the Missing Link in Platelet-Rich Plasma Therapies? An Evidence-Based Narrative Review.Journal of clinical medicine · 2026Review
- Mean platelet volume as a translational biomarker for cardiovascular risk stratification with perspectives for medical education: a systematic review.Global cardiology science & practice · 2026Review
- Platelet-Based Markers Associated With Vascular Access Dysfunction in Hemodialysis Patients.Cureus · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The medical field uses mean platelet volume (MPV) measurements as an essential diagnostic and monitoring indicator for diagnosing and following different conditions that include thrombotic and inflammatory diseases with diabetes and other hematological conditions. High mean platelet volume directly correlate with advanced medical conditions in cancer treatments as well as blood-related diseases which include platelet deficiencies. Mean platelet volume increases with inflammatory infections while offering important information about preeclampsia cases in pregnant women. Therefore, the mean platelet volume measurement enables assessment of platelet regulatory processes between production and destruction rate. Thus, this measurement allows healthcare providers to make better decisions regarding patient disease assessment and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.